ArticleDermatology and therapy2025

Correction: Analysis of Predefined Safety Events Across Spesolimab Trials in Dermatological and Non-Dermatological Conditions.

Kenneth B Gordon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.